nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—TYK2—trachea—pharynx cancer	0.00102	0.00175	CbGeAlD
Sunitinib—STK16—head—pharynx cancer	0.00101	0.00174	CbGeAlD
Sunitinib—HIPK2—head—pharynx cancer	0.00101	0.00173	CbGeAlD
Sunitinib—TYRO3—head—pharynx cancer	0.00101	0.00173	CbGeAlD
Sunitinib—ALK—head—pharynx cancer	0.00101	0.00173	CbGeAlD
Sunitinib—RIOK2—head—pharynx cancer	0.000999	0.00171	CbGeAlD
Sunitinib—MAP3K19—head—pharynx cancer	0.000989	0.0017	CbGeAlD
Sunitinib—KDR—parotid gland—pharynx cancer	0.000988	0.00169	CbGeAlD
Sunitinib—MAP2K5—parotid gland—pharynx cancer	0.000988	0.00169	CbGeAlD
Sunitinib—CLK4—lymph node—pharynx cancer	0.000987	0.00169	CbGeAlD
Sunitinib—RPS6KB1—trachea—pharynx cancer	0.000987	0.00169	CbGeAlD
Sunitinib—PRKAA1—lymphoid tissue—pharynx cancer	0.000981	0.00168	CbGeAlD
Sunitinib—MAP4K4—spinal cord—pharynx cancer	0.000979	0.00168	CbGeAlD
Sunitinib—AXL—trachea—pharynx cancer	0.000977	0.00167	CbGeAlD
Sunitinib—FLT1—epithelium—pharynx cancer	0.000977	0.00167	CbGeAlD
Sunitinib—SBK1—lymph node—pharynx cancer	0.000975	0.00167	CbGeAlD
Sunitinib—ITK—lymph node—pharynx cancer	0.000975	0.00167	CbGeAlD
Sunitinib—PTK2B—lymphoid tissue—pharynx cancer	0.00097	0.00166	CbGeAlD
Sunitinib—DAPK3—head—pharynx cancer	0.00097	0.00166	CbGeAlD
Sunitinib—FLT4—lymphoid tissue—pharynx cancer	0.000967	0.00166	CbGeAlD
Sunitinib—MAP3K12—spinal cord—pharynx cancer	0.000966	0.00166	CbGeAlD
Sunitinib—BLK—lymph node—pharynx cancer	0.000964	0.00165	CbGeAlD
Sunitinib—CLK2—head—pharynx cancer	0.000961	0.00165	CbGeAlD
Sunitinib—DAPK1—lymph node—pharynx cancer	0.000953	0.00163	CbGeAlD
Sunitinib—PHKG1—lymph node—pharynx cancer	0.000953	0.00163	CbGeAlD
Sunitinib—RPS6KA3—spinal cord—pharynx cancer	0.000952	0.00163	CbGeAlD
Sunitinib—KDR—saliva-secreting gland—pharynx cancer	0.000946	0.00162	CbGeAlD
Sunitinib—MAP2K5—saliva-secreting gland—pharynx cancer	0.000946	0.00162	CbGeAlD
Sunitinib—MAP2K1—spinal cord—pharynx cancer	0.000946	0.00162	CbGeAlD
Sunitinib—STK3—head—pharynx cancer	0.000943	0.00162	CbGeAlD
Sunitinib—SLK—trachea—pharynx cancer	0.00094	0.00161	CbGeAlD
Sunitinib—IRAK4—lymphoid tissue—pharynx cancer	0.000939	0.00161	CbGeAlD
Sunitinib—CSNK1A1—spinal cord—pharynx cancer	0.000934	0.0016	CbGeAlD
Sunitinib—ROCK1—head—pharynx cancer	0.000931	0.0016	CbGeAlD
Sunitinib—CLK1—spinal cord—pharynx cancer	0.000928	0.00159	CbGeAlD
Sunitinib—MAP2K5—brainstem—pharynx cancer	0.000927	0.00159	CbGeAlD
Sunitinib—JAK2—trachea—pharynx cancer	0.000927	0.00159	CbGeAlD
Sunitinib—BRD4—lymph node—pharynx cancer	0.000923	0.00158	CbGeAlD
Sunitinib—STK11—lymph node—pharynx cancer	0.000923	0.00158	CbGeAlD
Sunitinib—MAP2K2—lymphoid tissue—pharynx cancer	0.000919	0.00158	CbGeAlD
Sunitinib—FYN—trachea—pharynx cancer	0.000914	0.00157	CbGeAlD
Sunitinib—RPS6KA1—lymph node—pharynx cancer	0.000914	0.00157	CbGeAlD
Sunitinib—RIOK1—lymph node—pharynx cancer	0.000914	0.00157	CbGeAlD
Sunitinib—MAP3K2—lymphoid tissue—pharynx cancer	0.000912	0.00156	CbGeAlD
Sunitinib—BMP2K—spinal cord—pharynx cancer	0.000911	0.00156	CbGeAlD
Sunitinib—CAMK2G—spinal cord—pharynx cancer	0.000911	0.00156	CbGeAlD
Sunitinib—DYRK1A—head—pharynx cancer	0.000908	0.00156	CbGeAlD
Sunitinib—LRRK2—spinal cord—pharynx cancer	0.000902	0.00155	CbGeAlD
Sunitinib—MARK2—lymph node—pharynx cancer	0.000896	0.00154	CbGeAlD
Sunitinib—TNIK—lymph node—pharynx cancer	0.000896	0.00154	CbGeAlD
Sunitinib—MAP4K5—trachea—pharynx cancer	0.000893	0.00153	CbGeAlD
Sunitinib—MAP3K3—trachea—pharynx cancer	0.000893	0.00153	CbGeAlD
Sunitinib—TBK1—lymphoid tissue—pharynx cancer	0.000893	0.00153	CbGeAlD
Sunitinib—SGK3—lymph node—pharynx cancer	0.000888	0.00152	CbGeAlD
Sunitinib—TYK2—lymphoid tissue—pharynx cancer	0.000887	0.00152	CbGeAlD
Sunitinib—MERTK—head—pharynx cancer	0.000887	0.00152	CbGeAlD
Sunitinib—ICK—lymph node—pharynx cancer	0.000879	0.00151	CbGeAlD
Sunitinib—KIT—parotid gland—pharynx cancer	0.000876	0.0015	CbGeAlD
Sunitinib—MAP4K4—head—pharynx cancer	0.000871	0.00149	CbGeAlD
Sunitinib—FGFR1—spinal cord—pharynx cancer	0.000865	0.00148	CbGeAlD
Sunitinib—CSNK1E—spinal cord—pharynx cancer	0.000865	0.00148	CbGeAlD
Sunitinib—FLT1—trachea—pharynx cancer	0.000864	0.00148	CbGeAlD
Sunitinib—RPS6KB1—lymphoid tissue—pharynx cancer	0.000859	0.00147	CbGeAlD
Sunitinib—MAP3K12—head—pharynx cancer	0.000858	0.00147	CbGeAlD
Sunitinib—PDGFRB—parotid gland—pharynx cancer	0.000855	0.00147	CbGeAlD
Sunitinib—FGR—lymphoid tissue—pharynx cancer	0.000854	0.00146	CbGeAlD
Sunitinib—RET—lymphoid tissue—pharynx cancer	0.000854	0.00146	CbGeAlD
Sunitinib—EPHB6—trachea—pharynx cancer	0.000854	0.00146	CbGeAlD
Sunitinib—IRAK4—spinal cord—pharynx cancer	0.000852	0.00146	CbGeAlD
Sunitinib—AXL—lymphoid tissue—pharynx cancer	0.000851	0.00146	CbGeAlD
Sunitinib—CHEK2—lymph node—pharynx cancer	0.000849	0.00146	CbGeAlD
Sunitinib—NUAK1—lymph node—pharynx cancer	0.000849	0.00146	CbGeAlD
Sunitinib—RPS6KA3—head—pharynx cancer	0.000846	0.00145	CbGeAlD
Sunitinib—SNRK—lymph node—pharynx cancer	0.000842	0.00144	CbGeAlD
Sunitinib—INSR—lymph node—pharynx cancer	0.000842	0.00144	CbGeAlD
Sunitinib—OXSR1—lymph node—pharynx cancer	0.000842	0.00144	CbGeAlD
Sunitinib—MAP2K1—head—pharynx cancer	0.000841	0.00144	CbGeAlD
Sunitinib—KIT—saliva-secreting gland—pharynx cancer	0.000839	0.00144	CbGeAlD
Sunitinib—MAP2K2—spinal cord—pharynx cancer	0.000833	0.00143	CbGeAlD
Sunitinib—ULK3—spinal cord—pharynx cancer	0.000833	0.00143	CbGeAlD
Sunitinib—CSNK1A1—head—pharynx cancer	0.00083	0.00142	CbGeAlD
Sunitinib—STK38—lymph node—pharynx cancer	0.000829	0.00142	CbGeAlD
Sunitinib—RPS6KA2—lymph node—pharynx cancer	0.000829	0.00142	CbGeAlD
Sunitinib—KDR—epithelium—pharynx cancer	0.000826	0.00142	CbGeAlD
Sunitinib—YES1—trachea—pharynx cancer	0.000825	0.00141	CbGeAlD
Sunitinib—CLK1—head—pharynx cancer	0.000824	0.00141	CbGeAlD
Sunitinib—AURKC—lymph node—pharynx cancer	0.000823	0.00141	CbGeAlD
Sunitinib—KIT—brainstem—pharynx cancer	0.000822	0.00141	CbGeAlD
Sunitinib—MAP3K7—spinal cord—pharynx cancer	0.000819	0.0014	CbGeAlD
Sunitinib—PDGFRB—saliva-secreting gland—pharynx cancer	0.000819	0.0014	CbGeAlD
Sunitinib—PKN1—lymph node—pharynx cancer	0.000816	0.0014	CbGeAlD
Sunitinib—CSNK1G2—lymph node—pharynx cancer	0.000816	0.0014	CbGeAlD
Sunitinib—TAOK3—trachea—pharynx cancer	0.000814	0.0014	CbGeAlD
Sunitinib—TBK1—spinal cord—pharynx cancer	0.00081	0.00139	CbGeAlD
Sunitinib—CAMK2G—head—pharynx cancer	0.000809	0.00139	CbGeAlD
Sunitinib—BMP2K—head—pharynx cancer	0.000809	0.00139	CbGeAlD
Sunitinib—PDGFRA—trachea—pharynx cancer	0.000809	0.00139	CbGeAlD
Sunitinib—JAK2—lymphoid tissue—pharynx cancer	0.000807	0.00138	CbGeAlD
Sunitinib—TYK2—spinal cord—pharynx cancer	0.000804	0.00138	CbGeAlD
Sunitinib—PRPF4—lymph node—pharynx cancer	0.000804	0.00138	CbGeAlD
Sunitinib—LRRK2—head—pharynx cancer	0.000802	0.00138	CbGeAlD
Sunitinib—FYN—lymphoid tissue—pharynx cancer	0.000796	0.00136	CbGeAlD
Sunitinib—PRPF4B—lymph node—pharynx cancer	0.000793	0.00136	CbGeAlD
Sunitinib—PRKAA1—head—pharynx cancer	0.00079	0.00136	CbGeAlD
Sunitinib—STK39—lymph node—pharynx cancer	0.000782	0.00134	CbGeAlD
Sunitinib—PTK2B—head—pharynx cancer	0.000782	0.00134	CbGeAlD
Sunitinib—FLT4—head—pharynx cancer	0.000779	0.00134	CbGeAlD
Sunitinib—RPS6KB1—spinal cord—pharynx cancer	0.000779	0.00134	CbGeAlD
Sunitinib—MAP4K5—lymphoid tissue—pharynx cancer	0.000778	0.00133	CbGeAlD
Sunitinib—RET—spinal cord—pharynx cancer	0.000774	0.00133	CbGeAlD
Sunitinib—CSNK2A1—lymph node—pharynx cancer	0.000772	0.00132	CbGeAlD
Sunitinib—AXL—spinal cord—pharynx cancer	0.000771	0.00132	CbGeAlD
Sunitinib—CSNK1E—head—pharynx cancer	0.000769	0.00132	CbGeAlD
Sunitinib—MYLK—lymph node—pharynx cancer	0.000762	0.00131	CbGeAlD
Sunitinib—IRAK4—head—pharynx cancer	0.000757	0.0013	CbGeAlD
Sunitinib—PLK4—lymph node—pharynx cancer	0.000752	0.00129	CbGeAlD
Sunitinib—FLT1—lymphoid tissue—pharynx cancer	0.000752	0.00129	CbGeAlD
Sunitinib—STK4—lymph node—pharynx cancer	0.000748	0.00128	CbGeAlD
Sunitinib—SLK—spinal cord—pharynx cancer	0.000742	0.00127	CbGeAlD
Sunitinib—MAP2K2—head—pharynx cancer	0.00074	0.00127	CbGeAlD
Sunitinib—ULK3—head—pharynx cancer	0.00074	0.00127	CbGeAlD
Sunitinib—FGFR2—spinal cord—pharynx cancer	0.000736	0.00126	CbGeAlD
Sunitinib—MAP3K2—head—pharynx cancer	0.000735	0.00126	CbGeAlD
Sunitinib—PHKG2—lymph node—pharynx cancer	0.000735	0.00126	CbGeAlD
Sunitinib—JAK2—spinal cord—pharynx cancer	0.000732	0.00125	CbGeAlD
Sunitinib—KIT—epithelium—pharynx cancer	0.000732	0.00125	CbGeAlD
Sunitinib—STK24—lymph node—pharynx cancer	0.00073	0.00125	CbGeAlD
Sunitinib—KDR—trachea—pharynx cancer	0.00073	0.00125	CbGeAlD
Sunitinib—MAP2K5—trachea—pharynx cancer	0.00073	0.00125	CbGeAlD
Sunitinib—DAPK2—lymph node—pharynx cancer	0.000722	0.00124	CbGeAlD
Sunitinib—FYN—spinal cord—pharynx cancer	0.000722	0.00124	CbGeAlD
Sunitinib—TBK1—head—pharynx cancer	0.00072	0.00123	CbGeAlD
Sunitinib—YES1—lymphoid tissue—pharynx cancer	0.000718	0.00123	CbGeAlD
Sunitinib—TYK2—head—pharynx cancer	0.000715	0.00123	CbGeAlD
Sunitinib—PDGFRB—epithelium—pharynx cancer	0.000715	0.00123	CbGeAlD
Sunitinib—CSF1R—trachea—pharynx cancer	0.000712	0.00122	CbGeAlD
Sunitinib—STK10—lymphoid tissue—pharynx cancer	0.000712	0.00122	CbGeAlD
Sunitinib—STK16—lymph node—pharynx cancer	0.00071	0.00122	CbGeAlD
Sunitinib—TAOK3—lymphoid tissue—pharynx cancer	0.000709	0.00122	CbGeAlD
Sunitinib—HIPK3—lymph node—pharynx cancer	0.000707	0.00121	CbGeAlD
Sunitinib—HIPK2—lymph node—pharynx cancer	0.000707	0.00121	CbGeAlD
Sunitinib—ALK—lymph node—pharynx cancer	0.000707	0.00121	CbGeAlD
Sunitinib—MAP4K5—spinal cord—pharynx cancer	0.000705	0.00121	CbGeAlD
Sunitinib—MAP3K3—spinal cord—pharynx cancer	0.000705	0.00121	CbGeAlD
Sunitinib—PDGFRA—lymphoid tissue—pharynx cancer	0.000705	0.00121	CbGeAlD
Sunitinib—TNK1—lymph node—pharynx cancer	0.000699	0.0012	CbGeAlD
Sunitinib—RIOK2—lymph node—pharynx cancer	0.000699	0.0012	CbGeAlD
Sunitinib—MAP4K1—lymph node—pharynx cancer	0.000692	0.00119	CbGeAlD
Sunitinib—RPS6KB1—head—pharynx cancer	0.000692	0.00119	CbGeAlD
Sunitinib—FGR—head—pharynx cancer	0.000688	0.00118	CbGeAlD
Sunitinib—RET—head—pharynx cancer	0.000688	0.00118	CbGeAlD
Sunitinib—AXL—head—pharynx cancer	0.000685	0.00118	CbGeAlD
Sunitinib—FLT1—spinal cord—pharynx cancer	0.000682	0.00117	CbGeAlD
Sunitinib—DAPK3—lymph node—pharynx cancer	0.000679	0.00116	CbGeAlD
Sunitinib—EPHB6—spinal cord—pharynx cancer	0.000674	0.00116	CbGeAlD
Sunitinib—CLK2—lymph node—pharynx cancer	0.000673	0.00115	CbGeAlD
Sunitinib—MAP4K2—lymph node—pharynx cancer	0.00067	0.00115	CbGeAlD
Sunitinib—STK3—lymph node—pharynx cancer	0.00066	0.00113	CbGeAlD
Sunitinib—FGFR2—head—pharynx cancer	0.000654	0.00112	CbGeAlD
Sunitinib—YES1—spinal cord—pharynx cancer	0.000651	0.00112	CbGeAlD
Sunitinib—JAK2—head—pharynx cancer	0.00065	0.00112	CbGeAlD
Sunitinib—KIT—trachea—pharynx cancer	0.000647	0.00111	CbGeAlD
Sunitinib—TAOK3—spinal cord—pharynx cancer	0.000643	0.0011	CbGeAlD
Sunitinib—FYN—head—pharynx cancer	0.000641	0.0011	CbGeAlD
Sunitinib—PDGFRA—spinal cord—pharynx cancer	0.000639	0.0011	CbGeAlD
Sunitinib—KDR—lymphoid tissue—pharynx cancer	0.000636	0.00109	CbGeAlD
Sunitinib—DYRK1A—lymph node—pharynx cancer	0.000636	0.00109	CbGeAlD
Sunitinib—PDGFRB—trachea—pharynx cancer	0.000632	0.00108	CbGeAlD
Sunitinib—MAP3K3—head—pharynx cancer	0.000627	0.00107	CbGeAlD
Sunitinib—MAP4K5—head—pharynx cancer	0.000627	0.00107	CbGeAlD
Sunitinib—MERTK—lymph node—pharynx cancer	0.000621	0.00106	CbGeAlD
Sunitinib—CSF1R—lymphoid tissue—pharynx cancer	0.00062	0.00106	CbGeAlD
Sunitinib—MAP4K4—lymph node—pharynx cancer	0.00061	0.00105	CbGeAlD
Sunitinib—FLT1—head—pharynx cancer	0.000606	0.00104	CbGeAlD
Sunitinib—NUAK2—lymph node—pharynx cancer	0.000605	0.00104	CbGeAlD
Sunitinib—MAP3K12—lymph node—pharynx cancer	0.000601	0.00103	CbGeAlD
Sunitinib—FLT3—lymph node—pharynx cancer	0.000601	0.00103	CbGeAlD
Sunitinib—EPHB6—head—pharynx cancer	0.000599	0.00103	CbGeAlD
Sunitinib—RPS6KA3—lymph node—pharynx cancer	0.000593	0.00102	CbGeAlD
Sunitinib—MAP2K1—lymph node—pharynx cancer	0.000589	0.00101	CbGeAlD
Sunitinib—CSNK1A1—lymph node—pharynx cancer	0.000581	0.000996	CbGeAlD
Sunitinib—YES1—head—pharynx cancer	0.000579	0.000993	CbGeAlD
Sunitinib—CLK1—lymph node—pharynx cancer	0.000577	0.00099	CbGeAlD
Sunitinib—KDR—spinal cord—pharynx cancer	0.000576	0.000988	CbGeAlD
Sunitinib—MAP2K5—spinal cord—pharynx cancer	0.000576	0.000988	CbGeAlD
Sunitinib—STK10—head—pharynx cancer	0.000574	0.000984	CbGeAlD
Sunitinib—TAOK3—head—pharynx cancer	0.000571	0.00098	CbGeAlD
Sunitinib—PDGFRA—head—pharynx cancer	0.000568	0.000974	CbGeAlD
Sunitinib—BMP2K—lymph node—pharynx cancer	0.000567	0.000972	CbGeAlD
Sunitinib—CAMK2G—lymph node—pharynx cancer	0.000567	0.000972	CbGeAlD
Sunitinib—KIT—lymphoid tissue—pharynx cancer	0.000563	0.000966	CbGeAlD
Sunitinib—CSF1R—spinal cord—pharynx cancer	0.000563	0.000965	CbGeAlD
Sunitinib—LRRK2—lymph node—pharynx cancer	0.000562	0.000963	CbGeAlD
Sunitinib—PRKAA1—lymph node—pharynx cancer	0.000553	0.000949	CbGeAlD
Sunitinib—PDGFRB—lymphoid tissue—pharynx cancer	0.00055	0.000944	CbGeAlD
Sunitinib—PTK2B—lymph node—pharynx cancer	0.000547	0.000938	CbGeAlD
Sunitinib—FLT4—lymph node—pharynx cancer	0.000546	0.000936	CbGeAlD
Sunitinib—FGFR1—lymph node—pharynx cancer	0.000538	0.000923	CbGeAlD
Sunitinib—CSNK1E—lymph node—pharynx cancer	0.000538	0.000923	CbGeAlD
Sunitinib—IRAK4—lymph node—pharynx cancer	0.00053	0.000909	CbGeAlD
Sunitinib—ULK3—lymph node—pharynx cancer	0.000518	0.000889	CbGeAlD
Sunitinib—MAP2K2—lymph node—pharynx cancer	0.000518	0.000889	CbGeAlD
Sunitinib—MAP3K2—lymph node—pharynx cancer	0.000515	0.000882	CbGeAlD
Sunitinib—KDR—head—pharynx cancer	0.000512	0.000878	CbGeAlD
Sunitinib—MAP2K5—head—pharynx cancer	0.000512	0.000878	CbGeAlD
Sunitinib—KIT—spinal cord—pharynx cancer	0.000511	0.000876	CbGeAlD
Sunitinib—MAP3K7—lymph node—pharynx cancer	0.00051	0.000874	CbGeAlD
Sunitinib—TBK1—lymph node—pharynx cancer	0.000504	0.000864	CbGeAlD
Sunitinib—TYK2—lymph node—pharynx cancer	0.000501	0.000858	CbGeAlD
Sunitinib—CSF1R—head—pharynx cancer	0.0005	0.000857	CbGeAlD
Sunitinib—PDGFRB—spinal cord—pharynx cancer	0.000499	0.000855	CbGeAlD
Sunitinib—IRAK1—lymph node—pharynx cancer	0.000494	0.000847	CbGeAlD
Sunitinib—RPS6KB1—lymph node—pharynx cancer	0.000485	0.000831	CbGeAlD
Sunitinib—FGR—lymph node—pharynx cancer	0.000482	0.000826	CbGeAlD
Sunitinib—RET—lymph node—pharynx cancer	0.000482	0.000826	CbGeAlD
Sunitinib—ABCG2—parotid gland—pharynx cancer	0.000481	0.000824	CbGeAlD
Sunitinib—AXL—lymph node—pharynx cancer	0.00048	0.000823	CbGeAlD
Sunitinib—SLK—lymph node—pharynx cancer	0.000462	0.000792	CbGeAlD
Sunitinib—ABCG2—saliva-secreting gland—pharynx cancer	0.00046	0.000789	CbGeAlD
Sunitinib—JAK2—lymph node—pharynx cancer	0.000455	0.000781	CbGeAlD
Sunitinib—KIT—head—pharynx cancer	0.000454	0.000778	CbGeAlD
Sunitinib—FYN—lymph node—pharynx cancer	0.000449	0.00077	CbGeAlD
Sunitinib—PDGFRB—head—pharynx cancer	0.000443	0.00076	CbGeAlD
Sunitinib—MAP3K3—lymph node—pharynx cancer	0.000439	0.000753	CbGeAlD
Sunitinib—MAP4K5—lymph node—pharynx cancer	0.000439	0.000753	CbGeAlD
Sunitinib—FLT1—lymph node—pharynx cancer	0.000424	0.000728	CbGeAlD
Sunitinib—EPHB6—lymph node—pharynx cancer	0.000419	0.000719	CbGeAlD
Sunitinib—YES1—lymph node—pharynx cancer	0.000405	0.000695	CbGeAlD
Sunitinib—STK10—lymph node—pharynx cancer	0.000402	0.000689	CbGeAlD
Sunitinib—TAOK3—lymph node—pharynx cancer	0.0004	0.000686	CbGeAlD
Sunitinib—PDGFRA—lymph node—pharynx cancer	0.000398	0.000682	CbGeAlD
Sunitinib—MAP2K5—lymph node—pharynx cancer	0.000359	0.000615	CbGeAlD
Sunitinib—KDR—lymph node—pharynx cancer	0.000359	0.000615	CbGeAlD
Sunitinib—ABCC4—head—pharynx cancer	0.000353	0.000605	CbGeAlD
Sunitinib—CSF1R—lymph node—pharynx cancer	0.00035	0.0006	CbGeAlD
Sunitinib—KIT—lymph node—pharynx cancer	0.000318	0.000545	CbGeAlD
Sunitinib—KCNH2—spinal cord—pharynx cancer	0.000315	0.00054	CbGeAlD
Sunitinib—PDGFRB—lymph node—pharynx cancer	0.00031	0.000532	CbGeAlD
Sunitinib—ABCG2—spinal cord—pharynx cancer	0.00028	0.000481	CbGeAlD
Sunitinib—KCNH2—head—pharynx cancer	0.00028	0.00048	CbGeAlD
Sunitinib—ABCC4—lymph node—pharynx cancer	0.000247	0.000424	CbGeAlD
Sunitinib—ABCC2—lymph node—pharynx cancer	0.000239	0.00041	CbGeAlD
Sunitinib—ABCB1—epithelium—pharynx cancer	0.000198	0.00034	CbGeAlD
Sunitinib—KCNH2—lymph node—pharynx cancer	0.000196	0.000336	CbGeAlD
Sunitinib—ABCB1—trachea—pharynx cancer	0.000175	0.0003	CbGeAlD
Sunitinib—ABCG2—lymph node—pharynx cancer	0.000175	0.000299	CbGeAlD
Sunitinib—ABCB1—lymphoid tissue—pharynx cancer	0.000153	0.000262	CbGeAlD
Sunitinib—ABCB1—spinal cord—pharynx cancer	0.000138	0.000237	CbGeAlD
Sunitinib—ABCB1—head—pharynx cancer	0.000123	0.000211	CbGeAlD
Sunitinib—IRAK4—Immune System—CDH1—pharynx cancer	8.67e-05	0.000208	CbGpPWpGaD
Sunitinib—PHKG2—Disease—EGFR—pharynx cancer	8.67e-05	0.000208	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CNDP2—pharynx cancer	8.61e-05	0.000207	CbGpPWpGaD
Sunitinib—ABCB1—lymph node—pharynx cancer	8.61e-05	0.000148	CbGeAlD
Sunitinib—GRK1—Signaling Pathways—CCND1—pharynx cancer	8.56e-05	0.000205	CbGpPWpGaD
Sunitinib—CSNK1G2—Signaling Pathways—CCND1—pharynx cancer	8.56e-05	0.000205	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—CD79A—pharynx cancer	8.5e-05	0.000204	CbGpPWpGaD
Sunitinib—FGFR1—Adaptive Immune System—CDH1—pharynx cancer	8.48e-05	0.000204	CbGpPWpGaD
Sunitinib—RPS6KA3—Innate Immune System—EGFR—pharynx cancer	8.47e-05	0.000203	CbGpPWpGaD
Sunitinib—ROCK1—Developmental Biology—EGFR—pharynx cancer	8.47e-05	0.000203	CbGpPWpGaD
Sunitinib—PDGFRA—Adaptive Immune System—CDH1—pharynx cancer	8.46e-05	0.000203	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—CDH1—pharynx cancer	8.44e-05	0.000202	CbGpPWpGaD
Sunitinib—ITK—Immune System—EGFR—pharynx cancer	8.37e-05	0.000201	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by NGF—EGFR—pharynx cancer	8.34e-05	0.0002	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—CD79A—pharynx cancer	8.3e-05	0.000199	CbGpPWpGaD
Sunitinib—FGFR1—Axon guidance—EGFR—pharynx cancer	8.2e-05	0.000197	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling by NGF—EGFR—pharynx cancer	8.14e-05	0.000195	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—CCND1—pharynx cancer	8.11e-05	0.000195	CbGpPWpGaD
Sunitinib—CSNK1E—Cell Cycle—TP53—pharynx cancer	8.02e-05	0.000192	CbGpPWpGaD
Sunitinib—STK3—Signaling Pathways—EGFR—pharynx cancer	8.01e-05	0.000192	CbGpPWpGaD
Sunitinib—FYN—Immune System—CD79A—pharynx cancer	8e-05	0.000192	CbGpPWpGaD
Sunitinib—PAK3—Immune System—EGFR—pharynx cancer	7.99e-05	0.000192	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—CD79A—pharynx cancer	7.96e-05	0.000191	CbGpPWpGaD
Sunitinib—KDR—Developmental Biology—EGFR—pharynx cancer	7.95e-05	0.000191	CbGpPWpGaD
Sunitinib—STK4—Signaling Pathways—TP53—pharynx cancer	7.91e-05	0.00019	CbGpPWpGaD
Sunitinib—FYN—Signaling by NGF—EGFR—pharynx cancer	7.85e-05	0.000188	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by NGF—EGFR—pharynx cancer	7.8e-05	0.000187	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ADH7—pharynx cancer	7.78e-05	0.000187	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—CDH1—pharynx cancer	7.73e-05	0.000186	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—CDH1—pharynx cancer	7.62e-05	0.000183	CbGpPWpGaD
Sunitinib—CSNK2A1—Disease—EGFR—pharynx cancer	7.61e-05	0.000182	CbGpPWpGaD
Sunitinib—JAK2—Immune System—CD79A—pharynx cancer	7.6e-05	0.000182	CbGpPWpGaD
Sunitinib—FGR—Innate Immune System—EGFR—pharynx cancer	7.55e-05	0.000181	CbGpPWpGaD
Sunitinib—MAP2K2—Axon guidance—EGFR—pharynx cancer	7.55e-05	0.000181	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling by GPCR—EGFR—pharynx cancer	7.55e-05	0.000181	CbGpPWpGaD
Sunitinib—BLK—Immune System—CDH1—pharynx cancer	7.55e-05	0.000181	CbGpPWpGaD
Sunitinib—FGR—Immune System—CDH1—pharynx cancer	7.52e-05	0.00018	CbGpPWpGaD
Sunitinib—JAK2—Signaling by NGF—EGFR—pharynx cancer	7.46e-05	0.000179	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—CCND1—pharynx cancer	7.42e-05	0.000178	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—CDH1—pharynx cancer	7.35e-05	0.000176	CbGpPWpGaD
Sunitinib—BLK—Adaptive Immune System—EGFR—pharynx cancer	7.28e-05	0.000175	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—CCND1—pharynx cancer	7.14e-05	0.000171	CbGpPWpGaD
Sunitinib—FYN—Axon guidance—EGFR—pharynx cancer	7.1e-05	0.00017	CbGpPWpGaD
Sunitinib—MAP2K1—Axon guidance—EGFR—pharynx cancer	7.06e-05	0.000169	CbGpPWpGaD
Sunitinib—FGR—Hemostasis—TP53—pharynx cancer	7.04e-05	0.000169	CbGpPWpGaD
Sunitinib—RPS6KA5—Immune System—EGFR—pharynx cancer	6.97e-05	0.000167	CbGpPWpGaD
Sunitinib—YES1—Developmental Biology—EGFR—pharynx cancer	6.9e-05	0.000166	CbGpPWpGaD
Sunitinib—RPS6KA2—Immune System—EGFR—pharynx cancer	6.89e-05	0.000165	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ADH1B—pharynx cancer	6.83e-05	0.000164	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—CCND1—pharynx cancer	6.79e-05	0.000163	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—CCND1—pharynx cancer	6.79e-05	0.000163	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling by GPCR—EGFR—pharynx cancer	6.78e-05	0.000163	CbGpPWpGaD
Sunitinib—JAK2—Axon guidance—EGFR—pharynx cancer	6.75e-05	0.000162	CbGpPWpGaD
Sunitinib—STK3—Signaling Pathways—TP53—pharynx cancer	6.73e-05	0.000161	CbGpPWpGaD
Sunitinib—CSNK1G2—Signaling Pathways—EGFR—pharynx cancer	6.72e-05	0.000161	CbGpPWpGaD
Sunitinib—GRK1—Signaling Pathways—EGFR—pharynx cancer	6.72e-05	0.000161	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—CCND1—pharynx cancer	6.58e-05	0.000158	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—B4GALT5—pharynx cancer	6.52e-05	0.000157	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CNDP2—pharynx cancer	6.5e-05	0.000156	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—EGFR—pharynx cancer	6.37e-05	0.000153	CbGpPWpGaD
Sunitinib—TYK2—Developmental Biology—EGFR—pharynx cancer	6.35e-05	0.000152	CbGpPWpGaD
Sunitinib—RPS6KA1—Immune System—EGFR—pharynx cancer	6.19e-05	0.000149	CbGpPWpGaD
Sunitinib—YES1—Innate Immune System—EGFR—pharynx cancer	6.1e-05	0.000146	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—CCND1—pharynx cancer	6.07e-05	0.000146	CbGpPWpGaD
Sunitinib—YES1—Immune System—CDH1—pharynx cancer	6.07e-05	0.000146	CbGpPWpGaD
Sunitinib—CSNK1A1—Disease—EGFR—pharynx cancer	6.07e-05	0.000146	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	6.02e-05	0.000145	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ADH7—pharynx cancer	5.87e-05	0.000141	CbGpPWpGaD
Sunitinib—YES1—Adaptive Immune System—EGFR—pharynx cancer	5.85e-05	0.00014	CbGpPWpGaD
Sunitinib—FGFR1—Developmental Biology—EGFR—pharynx cancer	5.85e-05	0.00014	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—EGFR—pharynx cancer	5.82e-05	0.00014	CbGpPWpGaD
Sunitinib—IRAK1—Innate Immune System—EGFR—pharynx cancer	5.78e-05	0.000139	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—CDH1—pharynx cancer	5.76e-05	0.000138	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—CCND1—pharynx cancer	5.74e-05	0.000138	CbGpPWpGaD
Sunitinib—TBK1—Immune System—EGFR—pharynx cancer	5.69e-05	0.000137	CbGpPWpGaD
Sunitinib—YES1—Hemostasis—TP53—pharynx cancer	5.68e-05	0.000136	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—CCND1—pharynx cancer	5.68e-05	0.000136	CbGpPWpGaD
Sunitinib—GRK1—Signaling Pathways—TP53—pharynx cancer	5.64e-05	0.000135	CbGpPWpGaD
Sunitinib—CSNK1G2—Signaling Pathways—TP53—pharynx cancer	5.64e-05	0.000135	CbGpPWpGaD
Sunitinib—TYK2—Innate Immune System—EGFR—pharynx cancer	5.61e-05	0.000135	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—EGFR—pharynx cancer	5.61e-05	0.000134	CbGpPWpGaD
Sunitinib—TYK2—Immune System—CDH1—pharynx cancer	5.59e-05	0.000134	CbGpPWpGaD
Sunitinib—CAMK2G—Immune System—EGFR—pharynx cancer	5.59e-05	0.000134	CbGpPWpGaD
Sunitinib—FGFR2—Innate Immune System—EGFR—pharynx cancer	5.54e-05	0.000133	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—CDH1—pharynx cancer	5.52e-05	0.000132	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—EGFR—pharynx cancer	5.46e-05	0.000131	CbGpPWpGaD
Sunitinib—KIT—Innate Immune System—EGFR—pharynx cancer	5.44e-05	0.000131	CbGpPWpGaD
Sunitinib—MAP3K7—Innate Immune System—EGFR—pharynx cancer	5.44e-05	0.000131	CbGpPWpGaD
Sunitinib—KIT—Immune System—CDH1—pharynx cancer	5.42e-05	0.00013	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—CDH1—pharynx cancer	5.42e-05	0.00013	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—CCND1—pharynx cancer	5.41e-05	0.00013	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—EGFR—pharynx cancer	5.4e-05	0.00013	CbGpPWpGaD
Sunitinib—MAP2K2—Developmental Biology—EGFR—pharynx cancer	5.39e-05	0.000129	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—TP53—pharynx cancer	5.35e-05	0.000128	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—EGFR—pharynx cancer	5.33e-05	0.000128	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—EGFR—pharynx cancer	5.33e-05	0.000128	CbGpPWpGaD
Sunitinib—FGFR2—Adaptive Immune System—EGFR—pharynx cancer	5.32e-05	0.000128	CbGpPWpGaD
Sunitinib—MAP3K7—Adaptive Immune System—EGFR—pharynx cancer	5.23e-05	0.000125	CbGpPWpGaD
Sunitinib—KIT—Adaptive Immune System—EGFR—pharynx cancer	5.23e-05	0.000125	CbGpPWpGaD
Sunitinib—FGFR1—Innate Immune System—EGFR—pharynx cancer	5.17e-05	0.000124	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—EGFR—pharynx cancer	5.16e-05	0.000124	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—EGFR—pharynx cancer	5.15e-05	0.000124	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ADH1B—pharynx cancer	5.15e-05	0.000124	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—CDH1—pharynx cancer	5.15e-05	0.000123	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—CDH1—pharynx cancer	5.13e-05	0.000123	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—CCND1—pharynx cancer	5.1e-05	0.000122	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—EGFR—pharynx cancer	5.07e-05	0.000122	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—EGFR—pharynx cancer	5.07e-05	0.000122	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—CCND1—pharynx cancer	5.06e-05	0.000122	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—EGFR—pharynx cancer	5.04e-05	0.000121	CbGpPWpGaD
Sunitinib—FGFR1—Adaptive Immune System—EGFR—pharynx cancer	4.96e-05	0.000119	CbGpPWpGaD
Sunitinib—PDGFRA—Adaptive Immune System—EGFR—pharynx cancer	4.95e-05	0.000119	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—EGFR—pharynx cancer	4.93e-05	0.000118	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—B4GALT5—pharynx cancer	4.92e-05	0.000118	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—EGFR—pharynx cancer	4.9e-05	0.000118	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—TP53—pharynx cancer	4.89e-05	0.000117	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—EGFR—pharynx cancer	4.82e-05	0.000116	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—EGFR—pharynx cancer	4.77e-05	0.000114	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—EGFR—pharynx cancer	4.77e-05	0.000114	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—EGFR—pharynx cancer	4.76e-05	0.000114	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—CDH1—pharynx cancer	4.74e-05	0.000114	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	4.73e-05	0.000113	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—TP53—pharynx cancer	4.71e-05	0.000113	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—EGFR—pharynx cancer	4.64e-05	0.000111	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—CDH1—pharynx cancer	4.62e-05	0.000111	CbGpPWpGaD
Sunitinib—ABCC4—Hemostasis—TP53—pharynx cancer	4.59e-05	0.00011	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—EGFR—pharynx cancer	4.52e-05	0.000108	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—EGFR—pharynx cancer	4.5e-05	0.000108	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—EGFR—pharynx cancer	4.47e-05	0.000107	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—TP53—pharynx cancer	4.47e-05	0.000107	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—TP53—pharynx cancer	4.47e-05	0.000107	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—EGFR—pharynx cancer	4.46e-05	0.000107	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—EGFR—pharynx cancer	4.46e-05	0.000107	CbGpPWpGaD
Sunitinib—FYN—Immune System—CDH1—pharynx cancer	4.46e-05	0.000107	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—EGFR—pharynx cancer	4.45e-05	0.000107	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—CDH1—pharynx cancer	4.43e-05	0.000106	CbGpPWpGaD
Sunitinib—BLK—Immune System—EGFR—pharynx cancer	4.41e-05	0.000106	CbGpPWpGaD
Sunitinib—FGR—Immune System—EGFR—pharynx cancer	4.4e-05	0.000106	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—CCND1—pharynx cancer	4.37e-05	0.000105	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—TP53—pharynx cancer	4.34e-05	0.000104	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—EGFR—pharynx cancer	4.3e-05	0.000103	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—EGFR—pharynx cancer	4.25e-05	0.000102	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—EGFR—pharynx cancer	4.25e-05	0.000102	CbGpPWpGaD
Sunitinib—JAK2—Immune System—CDH1—pharynx cancer	4.24e-05	0.000102	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—TP53—pharynx cancer	4.17e-05	0.0001	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—CCND1—pharynx cancer	4.1e-05	9.85e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—CCND1—pharynx cancer	4.07e-05	9.76e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—EGFR—pharynx cancer	4e-05	9.61e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CNDP2—pharynx cancer	4e-05	9.6e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—TP53—pharynx cancer	4e-05	9.6e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—EGFR—pharynx cancer	3.97e-05	9.53e-05	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	3.97e-05	9.52e-05	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—TP53—pharynx cancer	3.97e-05	9.52e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—TP53—pharynx cancer	3.78e-05	9.07e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—TP53—pharynx cancer	3.74e-05	8.98e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—CCND1—pharynx cancer	3.73e-05	8.94e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ADH7—pharynx cancer	3.62e-05	8.68e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—CCND1—pharynx cancer	3.59e-05	8.61e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—EGFR—pharynx cancer	3.58e-05	8.58e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—TP53—pharynx cancer	3.57e-05	8.56e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—CCND1—pharynx cancer	3.57e-05	8.56e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—EGFR—pharynx cancer	3.55e-05	8.52e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—CCND1—pharynx cancer	3.46e-05	8.3e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—CCND1—pharynx cancer	3.46e-05	8.3e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—EGFR—pharynx cancer	3.43e-05	8.23e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—CCND1—pharynx cancer	3.37e-05	8.09e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—EGFR—pharynx cancer	3.37e-05	8.08e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—TP53—pharynx cancer	3.36e-05	8.07e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—TP53—pharynx cancer	3.34e-05	8e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—EGFR—pharynx cancer	3.27e-05	7.84e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—EGFR—pharynx cancer	3.23e-05	7.75e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—EGFR—pharynx cancer	3.22e-05	7.72e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—EGFR—pharynx cancer	3.19e-05	7.66e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ADH1B—pharynx cancer	3.17e-05	7.61e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—EGFR—pharynx cancer	3.17e-05	7.61e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—EGFR—pharynx cancer	3.17e-05	7.61e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—B4GALT5—pharynx cancer	3.03e-05	7.28e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—EGFR—pharynx cancer	3.03e-05	7.28e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—EGFR—pharynx cancer	3.02e-05	7.24e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—EGFR—pharynx cancer	3.01e-05	7.22e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—EGFR—pharynx cancer	3e-05	7.2e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—EGFR—pharynx cancer	2.98e-05	7.15e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—EGFR—pharynx cancer	2.93e-05	7.02e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—CCND1—pharynx cancer	2.93e-05	7.02e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—EGFR—pharynx cancer	2.92e-05	7.01e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—TP53—pharynx cancer	2.88e-05	6.91e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—EGFR—pharynx cancer	2.84e-05	6.81e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—EGFR—pharynx cancer	2.82e-05	6.76e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—EGFR—pharynx cancer	2.8e-05	6.71e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—EGFR—pharynx cancer	2.78e-05	6.67e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—CCND1—pharynx cancer	2.77e-05	6.66e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—EGFR—pharynx cancer	2.77e-05	6.65e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—EGFR—pharynx cancer	2.77e-05	6.65e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—EGFR—pharynx cancer	2.71e-05	6.51e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—EGFR—pharynx cancer	2.71e-05	6.51e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—EGFR—pharynx cancer	2.71e-05	6.51e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—EGFR—pharynx cancer	2.7e-05	6.49e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—TP53—pharynx cancer	2.7e-05	6.49e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—CCND1—pharynx cancer	2.69e-05	6.46e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—TP53—pharynx cancer	2.68e-05	6.43e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—CCND1—pharynx cancer	2.66e-05	6.38e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—EGFR—pharynx cancer	2.64e-05	6.34e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—CCND1—pharynx cancer	2.61e-05	6.27e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—CCND1—pharynx cancer	2.61e-05	6.27e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—EGFR—pharynx cancer	2.61e-05	6.25e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—EGFR—pharynx cancer	2.59e-05	6.22e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—EGFR—pharynx cancer	2.56e-05	6.14e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—EGFR—pharynx cancer	2.5e-05	5.99e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CCND1—pharynx cancer	2.48e-05	5.95e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—EGFR—pharynx cancer	2.48e-05	5.94e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CCND1—pharynx cancer	2.47e-05	5.93e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—TP53—pharynx cancer	2.45e-05	5.89e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—EGFR—pharynx cancer	2.41e-05	5.77e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—EGFR—pharynx cancer	2.39e-05	5.74e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TP53—pharynx cancer	2.36e-05	5.67e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TP53—pharynx cancer	2.35e-05	5.64e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—EGFR—pharynx cancer	2.3e-05	5.51e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—EGFR—pharynx cancer	2.29e-05	5.49e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CCND1—pharynx cancer	2.28e-05	5.48e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TP53—pharynx cancer	2.28e-05	5.47e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TP53—pharynx cancer	2.28e-05	5.47e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CCND1—pharynx cancer	2.23e-05	5.35e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TP53—pharynx cancer	2.22e-05	5.33e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—EGFR—pharynx cancer	2.18e-05	5.22e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CCND1—pharynx cancer	2.15e-05	5.15e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CCND1—pharynx cancer	2.14e-05	5.13e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—EGFR—pharynx cancer	2.11e-05	5.07e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—EGFR—pharynx cancer	2.09e-05	5.01e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—EGFR—pharynx cancer	2.05e-05	4.92e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—EGFR—pharynx cancer	2.05e-05	4.92e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CCND1—pharynx cancer	2.04e-05	4.9e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—EGFR—pharynx cancer	1.95e-05	4.67e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—EGFR—pharynx cancer	1.94e-05	4.66e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TP53—pharynx cancer	1.93e-05	4.62e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TP53—pharynx cancer	1.83e-05	4.39e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—EGFR—pharynx cancer	1.79e-05	4.3e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TP53—pharynx cancer	1.77e-05	4.26e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TP53—pharynx cancer	1.75e-05	4.2e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—EGFR—pharynx cancer	1.75e-05	4.19e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TP53—pharynx cancer	1.72e-05	4.13e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TP53—pharynx cancer	1.72e-05	4.13e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—EGFR—pharynx cancer	1.68e-05	4.04e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—EGFR—pharynx cancer	1.68e-05	4.02e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TP53—pharynx cancer	1.63e-05	3.92e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TP53—pharynx cancer	1.63e-05	3.91e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—EGFR—pharynx cancer	1.6e-05	3.84e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TP53—pharynx cancer	1.5e-05	3.61e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TP53—pharynx cancer	1.47e-05	3.52e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TP53—pharynx cancer	1.41e-05	3.39e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TP53—pharynx cancer	1.41e-05	3.38e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TP53—pharynx cancer	1.34e-05	3.23e-05	CbGpPWpGaD
